Columbia’s Osiris taps stem cells to build a better bandage for chronic wounds – Baltimore Business Journal

Osiris has a history of developing treatments — like Prochymal, the first government-approved stem cell drug — and then selling them to other companies. Its product portfolio is thus diverse, and that is wise when it comes to Grafix, which competes with a number of other advanced wound care products.